Keros Therapeutics (NASDAQ:KROS) Earns Buy Rating from HC Wainwright
HC Wainwright reiterated their buy rating on shares of Keros Therapeutics (NASDAQ:KROS – Free Report) in a research report released on Tuesday, Benzinga reports. The brokerage currently has a $100.00 price target on the stock. Other analysts have also recently issued research reports about the stock. Truist Financial reissued a buy rating and issued a […]
More Stories
SDX Energy (CVE:SDX) Stock Price Crosses Below Fifty Day Moving Average – Here’s What Happened
Shares of SDX Energy Inc (CVE:SDX – Get Free Report) crossed below its fifty day moving average during trading on...
Rollbit Coin Tops 1-Day Volume of $1.29 Million (RLB)
Rollbit Coin (RLB) traded 3.4% higher against the US dollar during the one day period ending at 13:00 PM ET...
Orbit Chain (ORC) One Day Volume Tops $108,666.55
Orbit Chain (ORC) traded down 5.6% against the US dollar during the 24 hour period ending at 13:00 PM ET...
Pirate Chain Price Down 8.6% Over Last Week (ARRR)
Pirate Chain (ARRR) traded down 2.6% against the U.S. dollar during the one day period ending at 13:00 PM ET...
Render Token (RNDR) Trading Down 0.9% Over Last 7 Days
Render Token (RNDR) traded up 0.1% against the US dollar during the 1 day period ending at 13:00 PM Eastern...
Dorel Industries (OTCMKTS:DIIBF) Shares Cross Below Fifty Day Moving Average – Here’s Why
Dorel Industries Inc. (OTCMKTS:DIIBF – Get Free Report) crossed below its 50 day moving average during trading on Thursday ....